Who backs Aktis Oncology?
23 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| T. Rowe Price Group | — |
| Bristol-Myers Squibb | — |
| RTW Investments | Hedge fund |
| Avidity Partners | Asset manager |
| EcoR1 Capital | Hedge fund |
| ArrowMark Partners | Asset manager |
| MPM BioImpact | Venture capital |
| Octagon Capital Advisors | Hedge fund |
| Baker Brothers Investments | Hedge fund |
| + 13 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Aktis Oncology
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 23 firms already write checks for companies like Aktis Oncology in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.